MedTrace Logo

Evaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery

NCT04654221 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2021-07-16

No results posted yet for this study

Summary

To evaluate the differences between serum cystatin C based estimated glomerular filtration rate (eGFRcys), serum creatinine based eGFR (eGFRcreat) and measured glomerular filtration rate (mGFR) in subjects at high risk for acute kidney injury (AKI) approximately 90 days following cardiac surgery

Conditions

  • Cardiac Surgery

Interventions

DIAGNOSTIC_TEST

mGFR by iohexol clearance

Iohexol 5mL injection (300 mg iodine/mL) will be administered to all subjects to determine mGFR by iohexol clearance

Sponsors & Collaborators

  • Quark Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Nitsan Halevy, MD · Quark Pharmaceuticals

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2021-02-25
Completion
2021-03-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04654221 on ClinicalTrials.gov